Understanding VPAC receptor family peptide binding and selectivity

Sarah J Piper; Giuseppe Deganutti; Jessica Lu; Peishen Zhao; Yi-Lynn Liang; Yao Lu; Madeleine M Fletcher; Mohammed Akhter Hossain; Arthur Christopoulos; Christopher A Reynolds; Radostin Danev; Patrick M Sexton; Denise Wootten

doi:10.1038/s41467-022-34629-3

Understanding VPAC receptor family peptide binding and selectivity

Nat Commun. 2022 Nov 16;13(1):7013. doi: 10.1038/s41467-022-34629-3.

Authors

Sarah J Piper^{1

2}, Giuseppe Deganutti³, Jessica Lu^{1

2}, Peishen Zhao^{1

2}, Yi-Lynn Liang^{1

4}, Yao Lu^{1

2}, Madeleine M Fletcher^{1

5}, Mohammed Akhter Hossain⁶, Arthur Christopoulos^{1

2}, Christopher A Reynolds^{3

7}, Radostin Danev⁸, Patrick M Sexton^{9

10}, Denise Wootten^{11

12}

Affiliations

¹ Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, VIC, Australia.
² ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, VIC, Australia.
³ Centre for Sport, Exercise and Life Sciences, Coventry University, CV1 5FB, Coventry, UK.
⁴ Confo TherapeuticsTechnologiepark 94, Ghent (Zwijnaarde), 9052, Belgium.
⁵ GlaxoSmithKline, Abbotsford, 3067, VIC, Australia.
⁶ Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, 3010, Australia.
⁷ School of Life Sciences, University of Essex, Wivenhoe Park, Colchester, CO4 3SQ, UK.
⁸ Graduate School of Medicine, University of Tokyo, S402, 7-3-1 Hongo, Bunkyo-ku, 113-0033, Tokyo, Japan.
⁹ Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, VIC, Australia. patrick.sexton@monash.edu.
¹⁰ ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, VIC, Australia. patrick.sexton@monash.edu.
¹¹ Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, VIC, Australia. denise.wootten@monash.edu.
¹² ARC Centre for Cryo-electron Microscopy of Membrane Proteins, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, 3052, VIC, Australia. denise.wootten@monash.edu.

Abstract

The vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) receptors are key regulators of neurological processes. Despite recent structural data, a comprehensive understanding of peptide binding and selectivity among different subfamily receptors is lacking. Here, we determine structures of active, Gs-coupled, VIP-VPAC1R, PACAP27-VPAC1R, and PACAP27-PAC1R complexes. Cryo-EM structural analyses and molecular dynamics simulations (MDSs) reveal fewer stable interactions between VPAC1R and VIP than for PACAP27, more extensive dynamics of VIP interaction with extracellular loop 3, and receptor-dependent differences in interactions of conserved N-terminal peptide residues with the receptor core. MD of VIP modelled into PAC1R predicts more transient VIP-PAC1R interactions in the receptor core, compared to VIP-VPAC1R, which may underlie the selectivity of VIP for VPAC1R over PAC1R. Collectively, our work improves molecular understanding of peptide engagement with the PAC1R and VPAC1R that may benefit the development of novel selective agonists.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Molecular Dynamics Simulation
Pituitary Adenylate Cyclase-Activating Polypeptide* / metabolism
Protein Binding
Vasoactive Intestinal Peptide* / metabolism

Substances

Pituitary Adenylate Cyclase-Activating Polypeptide
Vasoactive Intestinal Peptide